Targeting multiple myeloma with nanobody-based heavy chain antibodies, bispecific killer cell engagers, chimeric antigen receptors, and nanobody-displaying AAV vectors

Hambach, J; Mann, AM; Bannas, P; Koch-Nolte, F

Koch-Nolte, F (通讯作者)，Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany.

FRONTIERS IN IMMUNOLOGY, 2022; 13 ():

Abstract

Nanobodies are well suited for constructing biologics due to their high solubility. We generated nanobodies directed against CD38, a tumor marker that......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索